RNA5SP45

Across TCGA pan-cancer cohorts, RNA5SP45 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNA5SP45 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNA5SP45 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP45 expression acts as an unfavorable survival marker.

STAD, MESO, and KIRC are the cancer types where RNA5SP45 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.195	0.589	<.001	108	view →
MESO	OS	Tertile	II,III,IV	0.198	0.576	.004	63	view →
KIRC	DFS	Tertile	All	0.123	0.869	<.001	54	view →
PRAD	OS	Tertile	All	0.540	0.990	<.001	36	view →
BLCA	DFS	Tertile	III,IV	0.159	0.572	.036	9	view →
BRCA	DFS	Tertile	II,III,IV	0.228	0.527	.049	6	view →
UCEC	OS	Tertile	III,IV	0.556	0.835	.020	6	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNA5SP45–STAD (OS)

Open the STAD breakdown →